Valuation: Avantor, Inc.

Market Cap 923.91Cr 797.61Cr 748.28Cr 681.55Cr 1.28TCr 88TCr 1.3TCr 8.77TCr 3.44TCr 44TCr 3.47TCr 3.39TCr 1,47200Cr P/E 2026 *
40.9x
P/E 2027 * 29.3x
Enterprise Value 1.23TCr 1.06TCr 997.12Cr 908.19Cr 1.71TCr 1,17700Cr 1.73TCr 12TCr 4.58TCr 59TCr 4.62TCr 4.52TCr 1,96200Cr EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.73x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
24/07/26 Tax

Compliance Officer

-1,201 0.0002%
23/02/26 Tax

Compliance Officer

2,376 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%+0.52% - - 923.91Cr
-0.63%+1.80%-15.12%+5.38% 19TCr
-0.16%+1.83%-1.90%+11.64% 12TCr
+0.15%-3.23%+8.32%+74.73% 5.99TCr
-0.92%+2.96%+36.26%+64.79% 5.6TCr
-0.32%+1.71%-6.30%-33.69% 5TCr
-1.44%+0.98%+9.51%-17.91% 3.39TCr
-2.66%+2.48% - - 3.14TCr
-1.96%+10.41%-4.73%+24.70% 2.48TCr
+0.09%-0.68%+43.86%-10.98% 2.46TCr
Average -0.84%+3.26%+8.74%+14.83% 5.99TCr
Weighted average by Cap. -0.62%+3.30%+0.65%+15.31%

Financials

2026 *2027 *
Net sales 659.37Cr 569.23Cr 534.03Cr 486.4Cr 914.59Cr 63TCr 927.27Cr 6.26TCr 2.45TCr 32TCr 2.48TCr 2.42TCr 1,05100Cr 674.97Cr 582.7Cr 546.67Cr 497.91Cr 936.23Cr 65TCr 949.21Cr 6.41TCr 2.51TCr 32TCr 2.53TCr 2.48TCr 1,07600Cr
Net income 23Cr 19Cr 18Cr 17Cr 31Cr 2.15TCr 32Cr 213.75Cr 84Cr 1.08TCr 85Cr 83Cr 3.59TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.97TCr 44Cr 295.06Cr 115.63Cr 1.49TCr 116.68Cr 114.15Cr 4.95TCr
Net Debt 307.24Cr 265.24Cr 248.84Cr 226.65Cr 426.17Cr 29TCr 432.07Cr 2.92TCr 1.14TCr 15TCr 1.15TCr 1.13TCr 49TCr 244.13Cr 210.76Cr 197.72Cr 180.09Cr 338.62Cr 23TCr 343.32Cr 2.32TCr 908.28Cr 12TCr 916.56Cr 896.71Cr 39TCr
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
17/26/17 $13.57 -0.70% 11,30,331
14/26/14 $13.66 -1.37% 39,64,759
13/26/13 $13.85 -0.57% 59,35,599
12/26/12 $13.93 +1.16% 61,96,739
11/26/11 $13.77 +0.29% 76,44,967
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
13.66USD
Average target price
14.56USD
Spread / Average Target
+6.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock